Your browser doesn't support javascript.
loading
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.
Yanagisawa, Takafumi; Mori, Keiichiro; Katayama, Satoshi; Mostafaei, Hadi; Quhal, Fahad; Laukhtina, Ekaterina; Rajwa, Pawel; Motlagh, Reza Sari; Aydh, Abdulmajeed; König, Frederik; Grossmann, Nico C; Pradere, Benjamin; Miki, Jun; Kimura, Takahiro; Egawa, Shin; Shariat, Shahrokh F.
Afiliación
  • Yanagisawa T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090, Vienna, Austria.
  • Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Katayama S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090, Vienna, Austria.
  • Mostafaei H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090, Vienna, Austria.
  • Laukhtina E; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090, Vienna, Austria.
  • Motlagh RS; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Aydh A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090, Vienna, Austria.
  • König F; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Grossmann NC; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090, Vienna, Austria.
  • Pradere B; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Miki J; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090, Vienna, Austria.
  • Kimura T; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Egawa S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090, Vienna, Austria.
  • Shariat SF; Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Int J Clin Oncol ; 27(1): 59-71, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34757531
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Austria